Milton Brown
Fondateur chez SHUTTLE PHARMACEUTICALS HOLDINGS, INC.
Fortune : 436 749 $ au 30/04/2024
Profil
Milton Brown is the founder of Shuttle Pharmaceuticals, Inc. (founded in 2012) and Shuttle Pharmaceuticals Holdings, Inc. (founded in 2012).
He held the title of Director at both companies.
Dr. Brown's current job(s) include being a Director at Food Allergy Research & Education, Inc. and a Director-Drug Discovery Center at Georgetown University School of Medicine.
Dr. Brown's education history includes a doctorate degree from the University of Virginia and a doctorate degree from The University of Alabama School of Medicine.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 21/03/2024 | 1 094 610 ( 6,52% ) | 436 749 $ | 30/04/2024 |
Postes actifs de Milton Brown
| Sociétés | Poste | Début |
|---|---|---|
| SHUTTLE PHARMACEUTICALS HOLDINGS, INC. | Fondateur | 18/12/2012 |
Shuttle Pharmaceuticals, Inc.
 Shuttle Pharmaceuticals, Inc. BiotechnologyHealth Technology Shuttle Pharmaceuticals, Inc. operates as a pharmaceutical company which engages in the development and commercialization of drugs. It focuses on innovative drugs for sensitizing cancers to and protecting normal tissue from the effects of radiation therapy. The firm's products include novel HDAC inhibitor cancer drug candidates. The company was founded by Anatoly Dritschilo, Milton Brown, and Mira Jung in December 2012 and is headquartered in Rockville, MD. | Fondateur | 01/12/2012 |
| Georgetown University School of Medicine | Corporate Officer/Principal | 01/01/2012 |
Food Allergy Research & Education, Inc.
 Food Allergy Research & Education, Inc. Miscellaneous Commercial ServicesCommercial Services Food Allergy Research & Education, Inc. operates as a non-profit organization that provides food allergy research services. It offers programs and advocacy about food allergy awareness. It also provides information and performs fund-raising for research. The company was founded in 2012 and is headquartered in McLean, VA. | Directeur/Membre du Conseil | - |
Formation de Milton Brown
| The University of Alabama School of Medicine | Doctorate Degree |
| University of Virginia | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| SHUTTLE PHARMACEUTICALS HOLDINGS, INC. | Health Technology |
| Entreprise privées | 2 |
|---|---|
Shuttle Pharmaceuticals, Inc.
Shuttle Pharmaceuticals, Inc. BiotechnologyHealth Technology Shuttle Pharmaceuticals, Inc. operates as a pharmaceutical company which engages in the development and commercialization of drugs. It focuses on innovative drugs for sensitizing cancers to and protecting normal tissue from the effects of radiation therapy. The firm's products include novel HDAC inhibitor cancer drug candidates. The company was founded by Anatoly Dritschilo, Milton Brown, and Mira Jung in December 2012 and is headquartered in Rockville, MD. | Health Technology |
Food Allergy Research & Education, Inc.
Food Allergy Research & Education, Inc. Miscellaneous Commercial ServicesCommercial Services Food Allergy Research & Education, Inc. operates as a non-profit organization that provides food allergy research services. It offers programs and advocacy about food allergy awareness. It also provides information and performs fund-raising for research. The company was founded in 2012 and is headquartered in McLean, VA. | Commercial Services |